Siyamak Rasty
Chief Executive Officer bei Stellular Bio, Inc.
Vermögen: 29 489 $ am 31.03.2024
Profil
Siyamak Rasty is currently the President, Chief Executive Officer & Director at Stellular Bio, Inc. He previously served as an Independent Non-Executive Director at Oxford Biomedica Plc from 2020 to 2023.
Prior to that, he was the Vice President & Head-New Products at Shire Pharmaceuticals, Inc. from 2011 to 2016.
Siyamak also held the position of Chief Operating Officer at Homology Medicines, Inc. from 2016 to 2019.
He obtained his undergraduate and doctorate degrees from Louisiana State University in 1984 and 1989 respectively.
Additionally, Siyamak earned an MBA from Villanova University in 2002.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC
0,01% | 15.03.2023 | 11 614 ( 0,01% ) | 29 489 $ | 31.03.2024 |
Aktive Positionen von Siyamak Rasty
| Unternehmen | Position | Beginn |
|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Chief Executive Officer | 15.07.2019 |
Ehemalige bekannte Positionen von Siyamak Rasty
| Unternehmen | Position | Ende |
|---|---|---|
| OXFORD BIOMEDICA PLC | Director/Board Member | 23.06.2023 |
| Q32 BIO INC. | Chief Operating Officer | 12.07.2019 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Siyamak Rasty
| Louisiana State University | Doctorate Degree |
| Villanova University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
